A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
about
Current status and future directions of botulinum neurotoxins for targeting pain processingGenomes, neurotoxins and biology of Clostridium botulinum Group I and Group IIBotulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-RehabilitationWhy has Not There been More Research of Concern?Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm"Inconvenient truths" in the pursuit of scientific knowledge and public healthEthical alternatives to experiments with novel potential pandemic pathogens.Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm.Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.Tetanus neurotoxin utilizes two sequential membrane interactions for channel formation.Two novel toxin variants revealed by whole-genome sequencing of 175 Clostridium botulinum type E strainsGenetic characterization and comparison of Clostridium botulinum isolates from botulism cases in Japan between 2006 and 2011.Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strainsIsolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cellsRecombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo.Molecular epidemiology of infant botulism in California and elsewhere, 1976-2010.The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.Functional characterisation of germinant receptors in Clostridium botulinum and Clostridium sporogenes presents novel insights into spore germination systems.Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.A new synthesis for dual use research of concern.Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.Activity of botulinum neurotoxin type D (strain 1873) in human neurons.Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic ActivitySpatial, Temporal, and Matrix Variability of Clostridium botulinum Type E Toxin Gene Distribution at Great Lakes Beaches.Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery.Antimicrobial resistance is a global health emergencySystemic colonization of clover (Trifolium repens) by Clostridium botulinum strain 2301.The past and future of RRIFunctional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and BTranslocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epitheliaDNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challengeImplementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection.A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
P2860
Q26778129-9070EE9B-C01A-4D15-878F-604DC85A32B4Q26853403-422AAB20-A6C7-4023-8618-35F7ACF687A5Q28088625-99A06424-E516-4797-AE03-628B9BFE1412Q28655459-88F74139-0280-407C-8D10-27391CAA7000Q28660367-7BF928F0-FCB3-449D-95F8-FAB7B228F4A6Q28660966-D47665DD-2163-4E15-BF0A-799853B610D1Q30362738-5A14E97A-BAEF-41EA-B0AC-6A481B23AD7CQ33935194-CFD72017-AD91-40F7-8792-EC16947B31A9Q34057328-437724F3-0DE8-47B9-A43D-154271D588C8Q34070484-981AD477-7EBC-4FC9-AC4E-6F999C07A704Q34261184-8B4FFF84-25DC-44A8-AB22-885A8B59DC18Q34594221-6F44EB5F-975B-4DB5-B59C-D4CE0DB8D93DQ34595178-38CB32FF-B98E-4369-832C-7FD9E7984EC5Q34777569-781BFD26-B602-42AB-8DC7-C331C8CF158CQ35058841-07CA861A-AAB6-4C41-9047-F938E72DFA52Q35108894-59A29F49-7B68-42EE-A930-C2BF063016B2Q35184188-B0217CBB-2154-4058-B9B2-5F0978C83FE9Q35187115-28BC39D2-A8A3-4D87-8E25-60A77D43AFCCQ35187559-BC67F076-6391-460C-BA47-62DB9B21CB2BQ35247345-0DE2AC8D-FCE5-4A55-89E8-FA99530BE181Q35360802-860D0D22-A2CE-461A-AFC8-3EAB58E9AD42Q35416787-0C957F24-79E8-464A-930F-A33A3E4D71FEQ35542237-299617C7-885E-4710-B683-0EDB7F3529AEQ35563112-42453CA4-0770-4E01-93A3-407E233E79EBQ35690475-AE384610-8232-4B54-9665-89E342AFDA51Q35746555-BDFA99F9-6FD4-494E-9E07-324617AE67E1Q35764075-8E3D94C7-DC7B-4DD3-98EC-B6840F137850Q35768158-9F327922-B5A7-4084-BB78-83FDF30E98A1Q35802383-99560122-9E48-4E36-8758-844EC230F9F2Q35845993-41674D1A-BB9C-4A3E-A880-743D8CE01834Q35883661-842502F2-98D4-43E4-9024-4EBFEC469CD3Q35910511-B7E9FB09-D64B-4446-83AD-EB36E5F2BB40Q35968673-4093DB08-93AC-4D09-A219-D8DE07EF3FD6Q36023082-3A64D044-81D5-462F-9FF8-D71E000FACB0Q36033286-6B8BCD76-39C6-4CA4-9C43-03C39D90900DQ36112959-635835E3-A1FE-4BEC-AE1C-3C01B3A2BC7AQ36176597-DA9EFBB5-293E-4BC9-A202-2C2566AAB7D5Q36256249-32B85298-B51C-46A5-AFB5-18DDBE570C2EQ36304649-12ADD4C6-57A4-4425-A20F-65E877792E06Q36316488-144963A8-0826-4C37-8914-286032AEB400
P2860
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@en
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@nl
type
label
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@en
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@nl
prefLabel
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@en
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@nl
P2860
P356
P1476
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
@en
P2093
Jason R Barash
Stephen S Arnon
P2860
P304
P356
10.1093/INFDIS/JIT449
P407
P577
2013-10-07T00:00:00Z